Company Overview
- Headquarters
- 13208 E Shea Blvd. Suite 100, Scottsdale AZ
- Website
- td2inc.com
- Phone
- (602) 358-8300
- Employees
- 136
- Founded in
- 2003
- Industry
- Scientific Research
Financials & Stats
Revenue
$50B
Who is Translational Drug Development
Translational Drug Development (TD2) is a Contract Research Organization (CRO) based in Scottsdale, Arizona. The company employs 136 people and generates annual revenue of $50 million. TD2 specializes in oncology-focused drug development, supporting pharmaceutical companies through the preclinical, regulatory, and clinical trial phases. They provide a range of services designed to accelerate the development of medicines for life-threatening diseases, helping bring hope and improved quality of life to cancer patients. TD2 was founded in 2003 as a non-profit organization stemming from the Translational Genomics Research Institute (TGen). This heritage is evident in TD2's deep scientific expertise, particularly in understanding the "omic" drivers of disease, which informs the unique clinical strategies they develop for their clients. For more information, visit TD2's website at td2inc.com.
Company Leadership
Translational Drug Development Industry Tags
Companies Similar to Translational Drug Development
Analyze industry trends and opportunities by examining competitors and companies comparable to Translational Drug Development, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | 5 | |||
| 50M | Waltham, MA | |||
| 50M | 116 | Rutherford, NJ | 1999 | |
| 50M | ||||
| 50M | 3 | Madrid, CA |